Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B-Reference-Cited by-同舟云学术

Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B

Published:2006-06 Issue:7 Volume:130 Page:2039-2049
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Sherman Morris,Yurdaydin Cihan,Sollano Jose,Silva Marcelo,Liaw Yun–Fan,Cianciara Janusz,Boron–Kaczmarska Anna,Martin Paul,Goodman Zachary,Colonno Richard,Cross Anne,Denisky Gail,Kreter Bruce,Hindes Robert

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference39 articles.

1. Viral hepatitis B;Lai;Lancet,2004

2. Hepatitis B virus infection;Lee;N Engl J Med,1997

3. Predicting liver cirrhosis risk based on the level of circulating hepatitis B viral load;Iloeje;Gastroentrology,2006

4. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level;Chen;JAMA,2006

5. Asian-Pacific consensus statement on the management of chronic hepatitis B;Liaw;Liver Int,2005

Cited by 368 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of patients using lamivudine, entecavir, and tenofovir according to liver fibrosis markers fibrosis-4 and aspartate aminotransferase-to-platelet ratio index scores;Indian Journal of Pharmacology;2023-01

2. Antiviral Agents;Principles and Practice of Pediatric Infectious Diseases;2023

3. Treatment endpoints for chronic hepatitis D;Liver International;2022-10-13

4. Nucleosides and Nucleoside Analogues as Emerging Antiviral Drugs;Mini-Reviews in Organic Chemistry;2021-09-17

5. Expanding the Donor Pool;Annals of Surgery;2021-07-12